1-3 of 3
Jeffrey I. Cohen
Close
Sort by
Journal Articles

COVID-19 in patients with classic and variant hairy cell leukemia

Clinical Trials & Observations
Robert J. Kreitman, Theresa Yu, Lacey James, Julie Feurtado, Holly Eager, Olena Sierra Ortiz, Mory Gould, Jack Mauter, Hong Zhou, Peter D. Burbelo, Jeffrey I. Cohen, Hao-Wei Wang, Constance M. Yuan, Evgeny Arons
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7161–7168.
https://doi.org/10.1182/bloodadvances.2023011147
Published: 2023
Journal Articles

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Clinical Trials & Observations
Christopher Pleyer, Kerry J. Laing, Mir A. Ali, Christopher L. McClurkan, Susan Soto, Inhye E. Ahn, Pia Nierman, Emeline Maddux, Jennifer Lotter, Jeanine Superata, Xin Tian, Adrian Wiestner, Jeffrey I. Cohen, David M. Koelle, Clare Sun
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1732–1740.
https://doi.org/10.1182/bloodadvances.2021006574
Published: 2022
Includes: Supplemental data
Journal Articles

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

Clinical Trials & Observations
Blachy J. Dávila Saldaña, Tami John, Challice Bonifant, David Buchbinder, Sharat Chandra, Shanmuganathan Chandrakasan, Weni Chang, Leon Chen, Hannah L. Elfassy, Ashley V. Geerlinks, Roger H. Giller, Rakesh Goyal, David Hagin, Shahidul Islam, Kanwaldeep Mallhi, Holly K. Miller, William Owen, Martha Pacheco, Niraj C. Patel, Christiane Querfeld, Troy Quigg, Nameeta Richard, Deborah Schiff, Evan Shereck, Elizabeth Stenger, Michael B. Jordan, Helen E. Heslop, Catherine M. Bollard, Jeffrey I. Cohen
Journal: Blood Advances
Blood Adv (2022) 6 (2): 452–459.
https://doi.org/10.1182/bloodadvances.2021005291
Published: 2022
Includes: Supplemental data